Clinical characteristics associated with mortality of COVID-19 patients admitted to an intensive care unit of a tertiary hospital in South Africa.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
26
05
2021
accepted:
11
12
2022
entrez:
30
12
2022
pubmed:
31
12
2022
medline:
4
1
2023
Statut:
epublish
Résumé
Over 130 million people have been diagnosed with Coronavirus disease 2019 (COVID-19), and more than one million fatalities have been reported worldwide. South Africa is unique in having a quadruple disease burden of type 2 diabetes, hypertension, human immunodeficiency virus (HIV) and tuberculosis, making COVID-19-related mortality of particular interest in the country. The aim of this study was to investigate the clinical characteristics and associated mortality of COVID-19 patients admitted to an intensive care unit (ICU) in a South African setting. We performed a prospective observational study of patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection admitted to the ICU of a South African tertiary hospital in Cape Town. The mortality and discharge rates were the primary outcomes. Demographic, clinical and laboratory data were analysed, and multivariable robust Poisson regression model was used to identify risk factors for mortality. Furthermore, Cox proportional hazards regression model was performed to assess the association between time to death and the predictor variables. Factors associated with death (time to death) at p-value < 0.05 were considered statistically significant. Of the 402 patients admitted to the ICU, 250 (62%) died, and another 12 (3%) died in the hospital after being discharged from the ICU. The median age of the study population was 54.1 years (IQR: 46.0-61.6). The mortality rate among those who were intubated was significantly higher at 201/221 (91%). After adjusting for confounding, multivariable robust Poisson regression analysis revealed that age more than 48 years, requiring invasive mechanical ventilation, HIV status, procalcitonin (PCT), Troponin T, Aspartate Aminotransferase (AST), and a low pH on admission all significantly predicted mortality. Three main risk factors predictive of mortality were identified in the analysis using Cox regression Cox proportional hazards regression model. HIV positive status, myalgia, and intubated in the ICU were identified as independent prognostic factors. In this study, the mortality rate in COVID-19 patients admitted to the ICU was high. Older age, the need for invasive mechanical ventilation, HIV status, and metabolic acidosis were found to be significant predictors of mortality in patients admitted to the ICU.
Sections du résumé
BACKGROUND
Over 130 million people have been diagnosed with Coronavirus disease 2019 (COVID-19), and more than one million fatalities have been reported worldwide. South Africa is unique in having a quadruple disease burden of type 2 diabetes, hypertension, human immunodeficiency virus (HIV) and tuberculosis, making COVID-19-related mortality of particular interest in the country. The aim of this study was to investigate the clinical characteristics and associated mortality of COVID-19 patients admitted to an intensive care unit (ICU) in a South African setting.
METHODS AND FINDINGS
We performed a prospective observational study of patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection admitted to the ICU of a South African tertiary hospital in Cape Town. The mortality and discharge rates were the primary outcomes. Demographic, clinical and laboratory data were analysed, and multivariable robust Poisson regression model was used to identify risk factors for mortality. Furthermore, Cox proportional hazards regression model was performed to assess the association between time to death and the predictor variables. Factors associated with death (time to death) at p-value < 0.05 were considered statistically significant. Of the 402 patients admitted to the ICU, 250 (62%) died, and another 12 (3%) died in the hospital after being discharged from the ICU. The median age of the study population was 54.1 years (IQR: 46.0-61.6). The mortality rate among those who were intubated was significantly higher at 201/221 (91%). After adjusting for confounding, multivariable robust Poisson regression analysis revealed that age more than 48 years, requiring invasive mechanical ventilation, HIV status, procalcitonin (PCT), Troponin T, Aspartate Aminotransferase (AST), and a low pH on admission all significantly predicted mortality. Three main risk factors predictive of mortality were identified in the analysis using Cox regression Cox proportional hazards regression model. HIV positive status, myalgia, and intubated in the ICU were identified as independent prognostic factors.
CONCLUSIONS
In this study, the mortality rate in COVID-19 patients admitted to the ICU was high. Older age, the need for invasive mechanical ventilation, HIV status, and metabolic acidosis were found to be significant predictors of mortality in patients admitted to the ICU.
Identifiants
pubmed: 36584024
doi: 10.1371/journal.pone.0279565
pii: PONE-D-21-17355
pmc: PMC9803161
doi:
Types de publication
Observational Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0279565Informations de copyright
Copyright: © 2022 Nyasulu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Sci Rep. 2021 Mar 18;11(1):6283
pubmed: 33737527
Int J Public Health. 2020 Jun;65(5):533-546
pubmed: 32451563
Trop Med Infect Dis. 2022 Feb 03;7(2):
pubmed: 35202217
Am J Cardiovasc Drugs. 2020 Dec;20(6):571-590
pubmed: 32918209
J Intensive Care. 2020 Nov 23;8(1):88
pubmed: 33292649
J Autoimmun. 2020 May;109:102433
pubmed: 32113704
Ann Intern Med. 2021 Apr;174(4):581-582
pubmed: 33872541
J Crit Care. 2018 Oct;47:245-253
pubmed: 30059869
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Am J Respir Crit Care Med. 2021 Jan 1;203(1):3-4
pubmed: 33207122
Ir J Med Sci. 2021 Nov;190(4):1649-1652
pubmed: 33453014
Crit Care Med. 2017 May;45(5):781-789
pubmed: 28257335
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
Crit Care. 2021 Feb 11;25(1):58
pubmed: 33573680
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Curr Opin Crit Care. 2018 Oct;24(5):421-427
pubmed: 30045088
Cureus. 2020 Oct 12;12(10):e10906
pubmed: 33194473
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Crit Care. 2021 Mar 25;25(1):121
pubmed: 33766109
Am J Respir Crit Care Med. 2021 Jan 1;203(1):54-66
pubmed: 33119402
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Healthcare (Basel). 2022 Jul 19;10(7):
pubmed: 35885867
Chin Med J (Engl). 2020 May 5;133(9):1015-1024
pubmed: 32004165
BMC Med. 2021 Aug 30;19(1):213
pubmed: 34461893
New Microbes New Infect. 2021 May;41:100846
pubmed: 33614039
Intensive Care Med. 2020 Oct;46(10):1863-1872
pubmed: 32816098
S Afr Med J. 2020 Aug 26;110(10):973-981
pubmed: 33205723
Int J Cardiol Heart Vasc. 2020 Dec;31:100627
pubmed: 32875060
Front Immunol. 2022 Apr 11;13:866153
pubmed: 35479062
Front Med (Lausanne). 2021 Feb 23;8:629176
pubmed: 33708781
J Clin Med. 2020 Jun 04;9(6):
pubmed: 32512688
Front Med (Lausanne). 2020 Dec 09;7:585003
pubmed: 33363185
Indian J Med Microbiol. 2021 Apr;39(2):147-153
pubmed: 33966856
S Afr Med J. 2020 Jun 05;110(8):700-703
pubmed: 32880283
Clin Infect Dis. 2020 Dec 3;71(9):2459-2468
pubmed: 32358954
Clin Infect Dis. 2021 Oct 5;73(7):e2005-e2015
pubmed: 32860699
Int J Infect Dis. 2020 May;94:91-95
pubmed: 32173574
BMC Med Ethics. 2021 Mar 22;22(1):28
pubmed: 33752662
Lancet Respir Med. 2020 Dec;8(12):1233-1244
pubmed: 33075298
Eur Respir J. 2020 May 14;55(5):
pubmed: 32217650
HIV Med. 2021 May;22(5):372-378
pubmed: 33368966
S Afr Med J. 2020 Apr 23;110(6):463-465
pubmed: 32880553
Epidemiology. 2020 Nov;31(6):e49-e51
pubmed: 32773469
BMC Infect Dis. 2020 Oct 9;20(1):744
pubmed: 33036570
Clin Infect Dis. 2021 Oct 5;73(7):e1964-e1972
pubmed: 32905581
Infect Dis Clin North Am. 2010 Sep;24(3):693-703
pubmed: 20674799
Int J Lab Hematol. 2021 Apr;43(2):324-328
pubmed: 33010111
Front Cardiovasc Med. 2021 Feb 23;8:628885
pubmed: 33718452